Neuromuscular Electrical Stimulation for Muscle Wasting in Heart Failure Patients
Overview
Authors
Affiliations
Neuromuscular electrical stimulation (NMES) seems to be safe and beneficial in improvement in functional capacity, muscle strength, and quality of life when compared with conventional aerobic exercise, while the change in muscle fiber composition and muscle size was conflicting in patients with heart failure (HF). Moreover, NMES studies seem to have beneficial effects on pro-inflammatory cytokine, oxidative enzyme activity, and protein anabolic and catabolic metabolism that are the key molecular mechanism of muscle wasting in patients with HF. We review specific issues related to the effects of NMES on muscle wasting in patients with HF, whether NMES seems to be an alternative exercise modality preventing or improving in muscle wasting for HF patients who are unable or unwilling to engage in conventional exercise training; however no established strategies currently exist to focus on the patients with HF accompanied by muscle wasting.
Poltavskaya M, Sviridenko V, Giverts I, Patchenskaya I, Kozlovskaya I, Tomilovskaya E Open Heart. 2022; 9(2).
PMID: 35817498 PMC: 9274513. DOI: 10.1136/openhrt-2022-001965.
Aimo A, Saccaro L, Borrelli C, Fabiani I, Gentile F, Passino C Eur J Heart Fail. 2021; 23(9):1458-1467.
PMID: 34268843 PMC: 9292527. DOI: 10.1002/ejhf.2298.
Skeletal muscle wasting in chronic heart failure.
Suzuki T, Palus S, Springer J ESC Heart Fail. 2018; 5(6):1099-1107.
PMID: 30548178 PMC: 6300810. DOI: 10.1002/ehf2.12387.
Muscle wasting and sarcopenia in heart failure and beyond: update 2017.
Springer J, Springer J, Anker S ESC Heart Fail. 2017; 4(4):492-498.
PMID: 29154428 PMC: 5695190. DOI: 10.1002/ehf2.12237.